Net clinical benefit of antithrombotic therapy in patients with heart failure and sinus rhythm: A network meta-analysis from 5 clinical trials

Heart failure (HF) is associated with an increased incidence of thromboembolic events. Antithrombotic treatment could reduce the stroke risk, whereas increase the bleeding risk. Whether antithrombotic treatment should be a routine therapy for HF and sinus rhythm (SR) patients remains unanswered.

Source: Thrombosis Research - April 17, 2020 Category: Hematology Authors: Chi Zhang, Na Wang, Nan-Nan Shen, Ling-Cong Kong, Jie He, Yue Wu, Da Feng, Zhi-Chun Gu Tags: Review Article Source Type: research